Nisseiken Life Science (Zhejiang) Co., Ltd.

Nisseiken Life Science (Zhejiang) Co., Ltd. has been committed to the popularization and application of non-drug nutritional intervention NSKSD nattokinase for cardiovascular health for more than ten years. It has promoted the publication of China's first expert recommendations and guidelines on nattokinase, as well as China's first human clinical research report on NSKSD nattokinase. With the beautiful vision of "preventing stroke in the elderly and myocardial infarction in the middle-aged", we are responsible to consumers with the scientific conclusions of human clinical research.